Improving blood product management in placenta accreta patients with severe bleeding: institutional experience.
International journal of obstetric anesthesia(2023)
摘要
Given no significant morbidity or mortality, clinical judgment in experienced centers appears safe for the management of PAS patients undergoing CS. The adoption of an institutional protocol and point-of-care coagulation testing could decrease over-transfusion and associated complications.
更多查看译文
关键词
Placenta accreta spectrum, Blood product management, Overtransfusion, Point of care coagulation testing, Quality improvement
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要